SCHEMBL6651469

SCHEMBL6651469

CNc1ccc2c(c1)CN([C@@H](CCC(=O)O)C(=O)O)C2=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 4/20 0.54
SLC19A1 P41440 3/20 0.54
TYMS P04818 4/20 0.54
ALOX15 P16050 2/20 0.50
KDM4E B2RXH2 2/20 0.50
MAPT P10636 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ALDH1A1 P00352 1/20 0.44
TP53 P04637 1/20 0.44
GLA P06280 1/20 0.44
POLB P06746 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
HPGD P15428 1/20 0.44
ALOX12 P18054 1/20 0.44
NFKB1 P19838 1/20 0.44
APEX1 P27695 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44
SDCBP O00560 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6651478 1.00 DHFR (0.54) DHFRSLC19A1TYMSALOX15KDM4E
SCHEMBL6447536 0.81 DHFR (0.52) DHFRSLC19A1TYMSALOX15KDM4E
SCHEMBL6447529 0.81 DHFR (0.52) DHFRSLC19A1TYMSALOX15KDM4E
SCHEMBL7976084 0.80 LMNA (0.44) DHFRSLC19A1TYMSALOX15KDM4E
SCHEMBL29774638 0.80 ALOX15 (0.70) ALOX15KDM4EMAPTSMN1; SMN2ALDH1A1
SCHEMBL824555 0.80 ALOX15 (0.70) ALOX15KDM4EMAPTSMN1; SMN2ALDH1A1
SCHEMBL14533525 0.79 ALOX15 (0.47) DHFRSLC19A1TYMSALOX15KDM4E
SCHEMBL25032020 0.78 ALOX15 (0.40) ALOX15KDM4EMAPTSMN1; SMN2ALDH1A1
SCHEMBL26534076 0.76 DHFR (0.45) DHFRSLC19A1TYMSALOX15KDM4E
SCHEMBL27217283 0.76 DHFR (0.42) DHFRSLC19A1TYMSALOX15KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6762188-B1 INHIBITING THYMIDYLATE SYNTHASE; COLON, BREAST OR LUNG CARCINOMA SMITHKLINE BEECHAM CORPORATION 2004-07-13 US disclosed
EP-1199307-B1 Pharmaceutically active benzoquinazoline compounds WELLCOME FOUND (GB) 2004-02-25 EP disclosed
EP-1199307-A1 Pharmaceutically active benzoquinazoline compounds THE WELLCOME FOUNDATION LIMITED (GB) 2002-04-24 EP disclosed
US-6090941-A Pharmaceutically active benzoquinazoline compounds GLAXO WELLCOME INC. (US) 2000-07-18 US disclosed
US-5663337-A ENZYME, ANTITUMOR GLAXO WELLCOME INC. (US) 1997-09-02 US disclosed
US-5661155-A THYMIDYLATE SYNTHASE INHIBITOR; ADMINISTERING TO THE MAMMAL SUFFERING FROM LEUKEMIA OR TUMOR 2-(5-(((1,2-DIHYDRO-3-METHYL-1-OXOBENZO(F)QUINAZOLINE-9-YL) METHYL)AMINO)-1-OXO-2-ISOINDOLINYL)GLUTARIC ACID OR SALTS GLAXO WELLCOME INC. (US) 1997-08-26 US disclosed
US-5405851-A Administering benzoquinazoline thymidylate synthase inhibitors BURROUGHS WELLCOME CO. (US) 1995-04-11 US disclosed
EP-0535034-A1 PHARMACEUTICALLY ACTIVE BENZOQUINAZOLINE COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1993-04-07 EP disclosed
WO-1991019700-A1 PHARMACEUTICALLY ACTIVE BENZOQUINAZOLINE COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1991-12-26 WO disclosed